v3.25.2
DESCRIPTION OF THE COMPANY AND BASIS OF PRESENTATION (Tables)
12 Months Ended
Dec. 28, 2024
Accounting Policies [Abstract]  
Schedule of Effects of Restatements and Immaterial Revisions to Previously Issued Financial Statements
The effects of the restatements on the Consolidated Balance Sheet as of December 28, 2024 are as follows:

(millions)As ReportedAdjustmentAs Restated
Cash$40 $$47 
Inventories353 14 367 
Total current assets619 21 640 
Total assets1,962 21 1,983 
Accounts payable513 520 
Other current liabilities94 97 
Total current liabilities841 10 851 
Retained earnings16 11 27 
Total equity317 11 328 
Total liabilities and equity1,962 21 1,983 
Note A: Please refer to discussion in preceding paragraphs regarding adjustments to cash and accounts payable unrelated to the Error.
Note B: The Company's Consolidated Statements of Equity were also affected by the restated retained earnings amounts for the period presented above.
The effects of the revisions of errors not material to 2023 on the Consolidated Balance Sheet as of December 30, 2023 are as follows:
(millions)As ReportedAdjustmentAs Revised
Inventories345 348 
Total current assets706 709 
Total assets1,889 1,892 
Other current liabilities105 106 
Total current liabilities836 837 
Retained earnings3 
Total equity300 302 
Total liabilities and equity1,889 1,892 
Note: The Company's Consolidated Statements of Equity were also affected by the revised retained earnings amounts for the period presented above.

The effects of the restatements on the Consolidated Statement of Income and the Consolidated Statement of Comprehensive Income for the year ended December 28, 2024 are as follows:

(millions, except per share data)As ReportedAdjustmentAs Restated
Cost of goods sold$1,915 $(11)$1,904 
Operating profit109 11 120 
Income before income taxes85 11 96 
Income taxes13 15 
Net income72 81 
Comprehensive income58 67 
Basic earnings per share0.83 0.11 0.94 
Diluted earnings per share0.82 0.09 0.91 
The effects of the revisions of errors not material to 2023 on the Consolidated Statement of Income and the Consolidated Statement of Comprehensive Income for the year ended December 30, 2023 are as follows:

(millions, except per share data)As ReportedAdjustmentAs Revised
Cost of goods sold$2,009 $(3)$2,006 
Operating profit92 95 
Income before income taxes145 148 
Income taxes35 36 
Net income110 112 
Comprehensive income113 115 
Basic earnings per share1.28 0.03 1.31 
Diluted earnings per share1.28 0.03 1.31 
The effects of the restatements on the Consolidated Statement of Cash Flows for the year ended December 28, 2024 are as follows:
(millions)As ReportedAdjustmentAs Restated
Operating activities:
  Net Income$72 $$81 
  Changes in operating assets and liabilities:
     Inventories(12)(11)(23)
     Income taxes payable9 
     Accounts payable(67)(60)
Net cash provided by (used in) operating activities100 107 
Increase (decrease) in cash and cash equivalents(49)(42)
Cash and cash equivalents at end of period40 47 
Note: Please refer to discussion in preceding paragraphs regarding adjustments to cash and accounts payable unrelated to the Error.
The effects of the revision of errors not material to 2023 on the Consolidated Statement of Cash Flows for the year ended December 30, 2023 are as follows:
(millions)As ReportedAdjustmentAs Revised
Operating activities:
  Net Income$110 $$112 
  Changes in operating assets and liabilities:
     Inventories86 (3)83 
     Income taxes payable8 
Net cash provided by (used in) operating activities422 — 422 
The effects of the restatements on the Unaudited Consolidated Balance Sheets as of March 30, 2024, June 29, 2024 and September 28, 2024 are as follows:
March 30, 2024
(millions)As ReportedAdjustmentAs Restated
Cash$70 $$71 
Inventories328 333 
Total current assets664 670 
Total assets1,888 1,894 
Notes payable3 
Other current liabilities90 92 
Total current liabilities789 792 
Retained earnings20 23 
Total equity317 320 
Total liabilities and equity1,888 1,894 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.
Note B: The Company's Consolidated Statements of Equity were also affected by the restated retained earnings amounts for the period presented above.
June 29, 2024
(millions)As ReportedAdjustmentAs Restated
Cash$44 $$47 
Inventories360 12 372 
Total current assets642 15 657 
Total assets1,897 15 1,912 
Notes payable4 
Other current liabilities103 106 
Total current liabilities778 784 
Retained earnings37 46 
Total equity336 345 
Total liabilities and equity1,897 15 1,912 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.
Note B: The Company's Consolidated Statements of Equity were also affected by the restated retained earnings amounts for the period presented above.

September 28, 2024
(millions)As ReportedAdjustmentAs Restated
Cash$47 $$51 
Inventories339 16 355 
Total current assets602 20 622 
Total assets1,900 20 1,920 
Notes payable6 
Other current liabilities101 105 
Total current liabilities770 778 
Retained earnings11 12 23 
Total equity316 12 328 
Total liabilities and equity1,900 20 1,920 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.
Note B: The Company's Consolidated Statements of Equity were also affected by the restated retained earnings amounts for the period presented above.

The effects of the restatements on the Unaudited Consolidated Statement of Income and the Unaudited Consolidated Statement of Comprehensive Income for the quarters ended March 30, 2024, June 28, 2024, September 28, 2024 and December 28, 2024 and the year-to-date periods ended June 28, 2024 and September 28, 2024 are as follows:

For the quarter ended
March 30, 2024
(millions, except per share data)As ReportedAdjustmentAs Restated
Cost of goods sold$504 $(2)$502 
Operating profit46 48 
Income before income taxes44 46 
Income taxes11 12 
Net income33 34 
Comprehensive income30 31 
Basic earnings per share0.38 0.02 0.40 
Diluted earnings per share0.37 0.02 0.39 
For the quarter ended
June 29, 2024
For the year-to-date period ended June 29, 2024
(millions, except per share data)As ReportedAdjustmentAs RestatedAs ReportedAdjustmentAs Restated
Cost of goods sold$476 $(7)$469 $980 $(9)$971 
Operating profit47 54 93 102 
Income before income taxes43 50 87 96 
Income taxes12 13 23 25 
Net income31 37 64 71 
Comprehensive income28 34 58 65 
Basic earnings per share0.37 0.06 0.43 0.75 0.07 0.82 
Diluted earnings per share0.36 0.06 0.42 0.73 0.08 0.81 


For the quarter ended
September 28, 2024
For the year-to-date period ended September 28, 2024
(millions, except per share data)As ReportedAdjustmentAs RestatedAs ReportedAdjustmentAs Restated
Cost of goods sold$495 $(4)$491 $1,475 $(13)$1,462 
Operating profit(6)(2)87 13 100 
Income before income taxes(15)(11)72 13 85 
Income taxes (benefit)(4)(3)19 22 
Net income(11)(8)53 10 63 
Comprehensive income(11)(8)47 10 57 
Basic earnings per share(0.13)0.03 (0.10)0.62 0.11 0.73 
Diluted earnings per share(0.13)0.03 (0.10)0.60 0.11 0.71 

For the quarter ended
December 28, 2024
(millions, except per share data)As ReportedAdjustmentAs Restated
Cost of goods sold$440 $$442 
Operating profit22 (2)20 
Income before income taxes13 (2)11 
Income taxes (benefit)(6)(1)(7)
Net income19 (1)18 
Comprehensive income11 (1)10 
Basic earnings per share0.21 — 0.21 
Diluted earnings per share0.22 (0.02)0.20 

The effects of the revision of errors not material to 2023 on the Consolidated Statement of Income and the Consolidated Statement of Comprehensive Income for the quarter ended December 30, 2023 are as follows:

For the quarter ended
December 30, 2023
(millions, except per share data)As ReportedAdjustmentAs Revised
Cost of goods sold$465 $(3)$462 
Operating profit21 24 
Income before income taxes21 24 
Income taxes7 
Net income15 17 
Comprehensive income15 17 
Basic earnings per share0.18 0.03 0.21 
Diluted earnings per share0.18 0.03 0.21 
The effects of the restatements on the Unaudited Consolidated Statement of Cash Flows for the quarter ended March 30, 2024 and the year-to-date periods ended June 28, 2024 and September 28, 2024 are as follows:

For the quarter ended
March 30, 2024
(millions)As ReportedAdjustmentAs Restated
Operating activities:
  Net Income$33 $$34 
  Changes in operating assets and liabilities:
     Inventories16 (2)14 
     Income taxes payable
Net cash provided by (used in) operating activities10 — 10 
Financing activities:
     Net increase (reduction) of notes payable, with maturities less than or
     equal to 90 days
(3)(2)
Net cash provided by (used in) financing activities(19)(18)
Increase (decrease) in cash and cash equivalents(18)(17)
Cash and cash equivalents at end of period70 71 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.

For the year-to-date period ended
June 29, 2024
(millions)As ReportedAdjustmentAs Restated
Operating activities:
  Net Income$64 $$71 
  Changes in operating assets and liabilities:
     Inventories(17)(9)(26)
     Income taxes payable
Net cash provided by (used in) operating activities37 — 37 
Financing activities:
     Net increase (reduction) of notes payable, with maturities less than or
     equal to 90 days
(3)— 
Net cash provided by (used in) financing activities(33)(30)
Increase (decrease) in cash and cash equivalents(45)(42)
Cash and cash equivalents at end of period44 47 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.

For the year-to-date period ended
September 28, 2024
(millions)As ReportedAdjustmentAs Restated
Operating activities:
  Net Income$53 $10 $63 
  Changes in operating assets and liabilities:
     Inventories(13)(8)
     Income taxes payable
Net cash provided by (used in) operating activities98 — 98 
Financing activities:
     Net increase (reduction) of notes payable, with maturities less than or
     equal to 90 days
(2)
Net cash provided by (used in) financing activities(44)(40)
Increase (decrease) in cash and cash equivalents(42)(38)
Cash and cash equivalents at end of period47 51 
Note A: Please refer to Note 1 "Basis of Presentation" regarding adjustments to cash and notes payable unrelated to the Error.
Schedule of Allocated Expense from Former Parent
The allocation of expenses from Kellanova to WK Kellogg Co was reflected as follows in the Consolidated Financial Statements for the years-ended December 30, 2023 and December 31, 2022:
(millions)20232022
Cost of goods sold$128 $172 
Selling, general and administrative233 308 
Other (income) expense, net(43)106 
Total$318 $586